Novel phase I trial design to evaluate the addition of cediranib or selumetinib to preoperative chemoradiotherapy for locally advanced rectal cancer: the DREAMtherapy trial.
Marti FEM, Jayson GC, Manoharan P, O'Connor J, Renehan AG, Backen AC, Mistry H, Ortega F, Li K, Simpson KL, Allen J, Connell J, Underhill S, Misra V, Williams KJ, Stratford I, Jackson A, Dive C, Saunders MP.
Marti FEM, et al. Among authors: allen j.
Eur J Cancer. 2019 Aug;117:48-59. doi: 10.1016/j.ejca.2019.04.029. Epub 2019 Jun 21.
Eur J Cancer. 2019.
PMID: 31229949
Clinical Trial.